AUA 2014

auaAmerican Urological Association (AUA)
Annual Meeting
May 16 - 21, 2014

Orlando, Florida USA

#AUA14 - Multiparametric prostate MRI and MRI/ultrasound fusion biopsy in the follow-up of prostate cancer progression for men on active surveillance - Slide Presentation

ORLANDO, FL USA (UroToday.com) - Presented by Annerleim Walton Diaz,1 Nabeel Shakir,1 Soroush Rais-Bahrami MD,1 Baris Turkbey MD,2 Arvin K. George MD,1 Jason Rothwax,1 Lambros Stamatakis MD,1 C. William Hong,1 M. Minhaj Siddiqui MD,1 Chinonyerem Okoro,1 Dima Raskolnikov,1 Daniel Su MD,1 Hui Han MS,1 Joanna Shih PhD,5 Maria J. Merino MD,4 Richard Simon DSc,5 Bradford J. Wood MD,3 Peter L. Choyke MD2 and Peter A. Pinto MD,1, 3 at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

#AUA14 - Poster: Retrospective evaluation of efficacy and safety of Argus sling for treatment of male stress urinary incontinence: The Canadian experience

ORLANDO, FL USA (UroToday.com) - Presented by Geneviève Nadeau, Michael Sourial, Michel Bureau, Le-Mai Tu, Greg Bailly, Stephen S. Steele, Kevin Carlson, Richard Baverstock, Neil Dwyer, Luc Valiquette, Jean-Guy Vézina, and Sender Herschorn at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

#AUA14 - Poster: Stress urinary incontinence outcomes following transvaginal sling incision

ORLANDO, FL USA (UroToday.com) - Presented by Lara MacLachlan, MD,1 Justin Ellett, MD,1 Kelly Johnson, MD,2 Gini Ikwuezunma, MD,1 Michelle Koski, MD,3 Ross Rames, MD,1 Ahmed El-Zawahry, MD,4 and Eric Rovner MD1 at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

#AUA14 - Poster: Sexual dysfunction and dyspareunia in the setting of vaginal mesh exposure

ORLANDO, FL USA (UroToday.com) - Presented by Lara MacLachlan, MD,1 Justin Ellett, MD,1 Kelly Johnson, MD,2 Gini Ikwuezunma, MD,1 Michelle Koski, MD,3 Ross Rames, MD,1 Ahmed El-Zawahry, MD,4 and Eric Rovner MD1 at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

#AUA14 - Poster: Cell cycle progression score predicts metastatic progression of clear cell renal cell carcinoma after resection

ORLANDO, FL USA (UroToday.com) - Presented by Eric J. Askeland,1 Vincent A. Chehval,1 Ryan W. Askeland,2 Zaina Sangale,3 Steve Stone,3 Nafei Xu,3 Saradha Rajamani,3 Placede Fosso,3 and James A. Brown1 at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

#AUA14 - Poster: Multicenter validation study of a tissue epigenenic assay to predict histopathologically cancer-negative repeat prostate biopsies

ORLANDO, FL USA (UroToday.com) - Presented by Alan W. Partin, Eric A. Klein, Leonard S. Marks, Jason R. Gee, Dean A. Troyer, Leslie A. Mangold, Kimberly Rieger-­‐Christ, Joseph W. Bigley, Leander Van Neste, and Jonathan I. Epstein at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

#AUA14 - Poster: Overactive bladder patients ≥ 65 years of age have a similar efficacy and safety profile with onabotulinumtoxinA as patients less than 65 years of age

ORLANDO, FL USA (UroToday.com) - Presented by Courtenay Moore,1 Albert Kaufmann,2 Manher Joshi,3 Christopher Nardo,3 Yan Zheng,4 and Sender Herschorn5 at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

#AUA14 - Poster: Long-term efficacy and safety of repeat onabotulinumtoxinA treatment in overactive bladder syndrome and urinary incontinence: Third interim analysis, median 2.4 years follow-up

ORLANDO, FL USA (UroToday.com) - Presented by Victor Nitti,1 Christopher Chapple,2 David Sussman,3 Sidney Radomski,4 Peter Sand,5 Steven Guard,6 Christopher Nardo,7 Jihao Zhou,8 and Karl-Dietrich Sievert9 at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

#AUA14 - Poster: Reduction in urinary incontinence and improvement in quality of life with onabotulinumtoxinA in overactive bladder patients is unaffected by the use of clean intermittent catheterization or the presence of urinary tract infection

ORLANDO, FL USA (UroToday.com) - Presented by David Sussman,1 Jennifer Gruenenfelder,2 Heinrich Schulte-Baukloh,3 Steven Guard,4 Yan Zheng,5 and Karel Everaert6 at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

#AUA14 - Poster: Prognostic utility of the cell cycle progression (CCP) score generated from needle biopsy in men treated with prostatectomy

ORLANDO, FL USA (UroToday.com) - Presented by Jay T. Bishoff,1 Stephen J. Freedland,2 Leah Gerber,3 Pierre Tennstedt,4 Julia Reid,5 William Welbourn,5 Markus Graefen,4 Zaina Sangale,5 Eliso Tikishvili,5 Jimmy Park,5 Adib Younus,5 Alexander Gutin,5 Jerry S. Lanchbury,5 Guido Sauter,6 Michael Brawer,5 Steven Stone,5 and Thorsten Schlomm4 at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

#AUA14 - Poster: Validation of a 46-gene cell cycle progression (CCP) RNA signature for predicting prostate cancer death in a conservatively managed watchful waiting needle biopsy cohort

ORLANDO, FL USA (UroToday.com) - Presented by Jack Cuzick, Steven Stone, Zi Hua Yang, Julia Reid, Gabrielle Fisher, Daniel Berney, Luis Beltran, Henrik Moller, David Greenberg, Michael Brawer, Alexander Gutin, Jerry Lanchbury, and Peter Scardino at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

#AUA14 - Poster: Predicting radical prostatectomy outcome among men who upgrade from clinical Gleason 6 to pathologic Gleason 7

ORLANDO, FL USA (UroToday.com) - Presented by Matthew Cooperberg, Stephen J. Freedland, Thorsten Schlomm, Julia E. Reid, Steven Stone, and Michael K. Brawer at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

#AUA14 - Poster: Anticholinergic cycling and treatment outcomes in overactive bladder patients with urinary incontinence

ORLANDO, FL USA (UroToday.com) - Presented by Michael B. Chancellor,1 Riya Pulicharam,2 I-Ning Cheng,2 Karen Campbell,3 Catherine Corbell,3 Manher Joshi,3 and Denise Globe3 at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

#AUA14 - Impact of female stress urinary incontinence surgery on pre-op overactive bladder symptoms - Session Highlights

ORLANDO, FL USA (UroToday.com) - The aim of this study was to describe the impact of various stress urinary incontinence (SUI) procedures on pre-operative overactive bladder (OAB) symptoms, up to 5 years after surgery.

#AUA14 - Poster: Treatment practice patterns in metastatic castration-resistant prostate cancer patients prior to receiving sipuleucel-T: Data from PROCEED

ORLANDO, FL USA (UroToday.com) - Presented by Matthew R. Cooperberg,1 Oliver Sartor,2 Andrew J. Armstrong,3 Christopher M. Pieczonka,4 Raoul S. Concepcion,5 Vahan Kassabian,6 Ronald F. Tutrone,7 James L. Bailen,8 Neal D. Shore,9Lawrence I. Karsh,10 Bernard L. Hertzman,11 David F. Penson,12 Candice Mccoy,13 Andrew Sandler,13 Robert C. Tyler,13 James B. Whitmore,13 and Celestia S. Higano14 at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

#AUA14 - Poster: Further characterization of the effects of prior or no prior docetaxel therapy on CRPC patients with bone metastases receiving Ra-223 in the phase 3 ALSYMPCA trial

ORLANDO, FL USA (UroToday.com) - Presented by Neal D. Shore,1 Nicholas J. Vogelzang,2 Peter Hoskin,3 Sten Nilsson,4 Robert Coleman,5 Christopher Parker,6 Mona Wahba,7 Karin Staudacher,8 and Oliver Sartor9 at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

#AUA14 - Poster: Impact of prior endocrine therapy on clinical benefit of abiraterone acetate in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer: Results from COU-AA-302

ORLANDO, FL USA (UroToday.com) - Presented by Fred Saad,1 Thian Kheoh,2 Margaret K. Yu,2 Matthew R. Smith,3 Eric J. Small,4 Peter F.A. Mulders,5 Karim Fizazi,6 Dana E. Rathkopf,7 Stéphane Oudard,8 Howard I. Scher,7 Joaquim Bellmunt,9 Mary-Ellen Taplin,9 Ian D. Davis,10 Dirk Schrijvers,11 Andrew Protheroe,12 Arturo Molina,13 Thomas W. Griffin,2 Johann S. de Bono,14 and Charles J. Ryan4 at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

#AUA14 - Poster: An indirect treatment comparison and cost-effectiveness analysis of abiraterone acetate and enzalutamide for the treatment of metastatic castration-resistant prostate cancer post chemotherapy

ORLANDO, FL USA (UroToday.com) - Presented by Melissa Thompson,1 Tracy Li,2 Mary B. Todd,2 Margaret K. Yu,4 Thian Kheoh,3 Jianming He,2 and Ryan Saadi2 at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe